Metraipolis › archive › dc_bb4fc99de781

MOG-Ab-associated optic neuritis with concurrent GFAP-Ab positivity following tislelizumab-based treatment: a case report — Europe PMC PMID:42466004

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42466004
DOI
10.3389/fphar.2026.1834795
License (as archived)
solo-consultazione
Archived
2026-10-18T11:50:00.855Z
SHA-256 of the archived text
823d93eec35d3f0c68f14e4bf941e9e92f3af4b74834b35fe87e4954714583ed
Stable URL of this page
https://metraipolis.com/documento/dc_bb4fc99de781

How to cite

MOG-Ab-associated optic neuritis with concurrent GFAP-Ab positivity following tislelizumab-based treatment: a case report — Europe PMC PMID:42466004 — Europe PMC (en), https://europepmc.org/article/MED/42466004 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb4fc99de781 (Metraipolis archive dc_bb4fc99de781, sha256 823d93eec35d3f0c68f14e4bf941e9e92f3af4b74834b35fe87e4954714583ed)
BibTeX
@misc{dcbb4fc99de781,
  title = {MOG-Ab-associated optic neuritis with concurrent GFAP-Ab positivity following tislelizumab-based treatment: a case report — Europe PMC PMID:42466004},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42466004},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb4fc99de781; sha256 823d93eec35d3f0c68f14e4bf941e9e92f3af4b74834b35fe87e4954714583ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42466004. Agents can read the archived copy with the MCP tool read_document.